Darolutamide plus ADT and Docetaxel Improves Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer.
| Publicado en: | Oncology Nurse-APN/PA Vol. 15; no. 3; p. 21 |
|---|---|
| Autor principal: | |
| Formato: | brief item pictorial Journal Article |
| Publicado: |
Amplity Health
Jun2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |